Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON)

N. Thielen, B. van der Holt, J.J. Cornelissen, G.E.G. Verhoef, T. Gussinklo, B.J. Biemond, S.M.G. Daenen, W. Deenik, R.V. Kooy, E. Petersen, W.M. Smit, P.J.M. Valk, G.J. Ossenkoppele, J.J.W.M. Janssen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3242-3246
JournalEuropean Journal of Cancer
Issue number15
Publication statusPublished - 2013

Cite this